A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome
Courtney D. DiNardo, Andreas Hochhaus, Mark G. Frattini, Karen Yee, Thomas Zander, Alwin Krämer, Xueying Chen, Yan Ji, Nehal S. Parikh, Joanne Jung Eun Choi, Andrew H. Wei
Topics & Concepts
MedicineMyeloid leukemiaAdverse effectInternal medicineNauseaGastroenterologyNeutropeniaMyeloidPharmacologyToxicityOncologyAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchRetinoids in leukemia and cellular processes